<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>38(1)</volume><submitter>Sanden G</submitter><funding>Umea University</funding><funding>Knut och Alice Wallenbergs Stiftelse</funding><pubmed_abstract>&lt;h4>Aim&lt;/h4>To investigate whether patients with endoscopically untraversable rectal cancer may benefit from a defunctioning stoma created before neoadjuvant therapy or resectional surgery.&lt;h4>Methods&lt;/h4>This retrospective study comprise patients diagnosed with rectal cancer during 2007-2020 in Region Västerbotten, Sweden. The primary outcome was time between diagnosis and any treatment, while survival and the incidence of complications were secondary outcomes. Excluded were patients without endoscopic obstruction, patients already having a stoma, patients with recurrent disease, palliative patients, and patients receiving a stoma shortly after diagnosis due to any urgent bowel-related complication. Data were obtained from the Swedish Colorectal Cancer Registry and medical records. Kaplan</pubmed_abstract><journal>International journal of colorectal disease</journal><pagination>24</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9877073</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Defunctioning stoma before neoadjuvant treatment or resection of endoscopically obstructing rectal cancer.</pubmed_title><pmcid>PMC9877073</pmcid><pubmed_authors>Svensson J</pubmed_authors><pubmed_authors>Ljuslinder I</pubmed_authors><pubmed_authors>Sanden G</pubmed_authors><pubmed_authors>Rutegard M</pubmed_authors></additional><is_claimable>false</is_claimable><name>Defunctioning stoma before neoadjuvant treatment or resection of endoscopically obstructing rectal cancer.</name><description>&lt;h4>Aim&lt;/h4>To investigate whether patients with endoscopically untraversable rectal cancer may benefit from a defunctioning stoma created before neoadjuvant therapy or resectional surgery.&lt;h4>Methods&lt;/h4>This retrospective study comprise patients diagnosed with rectal cancer during 2007-2020 in Region Västerbotten, Sweden. The primary outcome was time between diagnosis and any treatment, while survival and the incidence of complications were secondary outcomes. Excluded were patients without endoscopic obstruction, patients already having a stoma, patients with recurrent disease, palliative patients, and patients receiving a stoma shortly after diagnosis due to any urgent bowel-related complication. Data were obtained from the Swedish Colorectal Cancer Registry and medical records. Kaplan</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Jan</publication><modification>2025-04-26T01:45:03.582Z</modification><creation>2025-02-18T23:26:11.31Z</creation></dates><accession>S-EPMC9877073</accession><cross_references><pubmed>36698033</pubmed><doi>10.1007/s00384-023-04318-8</doi></cross_references></HashMap>